Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy

NCT05270278 is registered in ClinicalTrials.gov with Value Outcomes Ltd. as lead sponsor.

NCT NCT05270278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05270278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
Lead sponsor
Value Outcomes Ltd.
Phase
Observational
Overall status
Completed
Start date
August 16, 2022
Completion date
March 31, 2023
Enrollment
89 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma chronic, asthma, bronchial, asthma; eosinophilic, bronchial asthma